Skip to content

Drug interactions

Anagrelide + Arformoterol

Severity: Moderate

Anagrelide and Arformoterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anagrelide and the long-acting beta-agonist arformoterol can each prolong QTc and provoke tachyarrhythmias. Combined use may increase the risk of serious ventricular arrhythmias, especially with low potassium or heart disease.

What this interaction means in plain words

Anagrelide and Arformoterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Anagrelide belongs to Cardiovascular; Arformoterol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive QT prolongation with beta-agonist-induced hypokalemia and increased heart rate.

What to do

Obtain a baseline ECG and monitor potassium and magnesium. Watch for palpitations or syncope, and consider alternatives in patients with existing arrhythmia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Arformoterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Anagrelide with Arformoterol?

MediHelp rates the interaction as moderate. Anagrelide and Arformoterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anagrelide and the long-acting beta-agonist arformoterol can each prolong QTc and provoke tachyarrhythmias. Combined use may increase the risk of serious ventricular arrhythmias, especially with low potassium or heart disease.

How serious is the interaction between Anagrelide and Arformoterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor potassium and magnesium. Watch for palpitations or syncope, and consider alternatives in patients with existing arrhythmia.

What other medicines interact with Anagrelide?

MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in